Brief: Microbot Medical Announces Positive Results Of Its GLP Pivotal Pre-Clinical Study
28/12/2023 12:44
Dec 28 (Reuters) - Microbot Medical Inc MBOT.O :
* MICROBOT MEDICAL ANNOUNCED POSITIVE RESULTS OF ITS GLP
PIVOTAL
PRE-CLINICAL STUDY WHERE ALL STUDY OBJECTIVES WERE MET
* MICROBOT MEDICAL INC: EXPECT TO SUBMIT OUR IDE APPLICATION
TO
FDA SOON AND COMMENCE OUR PIVOTAL HUMAN CLINICAL TRIAL
Source text for Eikon: ID:nGNX3nG0CK
Further company coverage: MBOT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microbot Medical
See all newsBrief: Microbot Medical® Enters Into An Agreement To Expand Access For America’S Veteran And Military Patient Populations
Microbot Medical rises as U.S. federal supply deal expands reach of robotic surgical device
Brief: Microbot Medical Recorded Revenue During Its Quarter Ended March 31, Benefiting From Limited Market Release Of Liberty System
Brief: Microbot Medical®’S Liberty® Endovascular Robotic System Is Now Adopted By Multiple Accounts Across Key Territories Including Two Access-Pvi Pivotal Clinical Trial Sites
Brief: Microbot Medical Continues Its 2025 Momentum Announces Key 2026 Milestones